Literature DB >> 28613283

Risk Factors for No-Reflow Phenomenon after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome.

Tian Liang1,2, Min Liu1, Chengyu Wu1, Qing Zhang1, Lei Lu1, Zhongliang Wang1.   

Abstract

BACKGROUND: To explore risk factors for no-reflow phenomenon after percutaneous coronary intervention in patients with acute coronary syndrome.
METHODS: A total of 733 acute myocardial infarction patients with persistent ischemic chest pain within 12 or 12-24 hours after onset received emergency percutaneous coronary intervention. Patients were divided into a normal reflow group and a no-reflow group, according to TIMI grading and myocardial blush grading after percutaneous coronary intervention. Related risk factors were analyzed.
RESULTS: The incidence of no-reflow phenomenon after percutaneous coronary intervention was 16.1%. Univariate analysis showed that, compared with the normal reflow group, the no-reflow group was older, reperfusion time was significantly longer, preoperative systolic pressure was lower, troponin peak was higher, and creatine kinase enzyme peak was higher (p < 0.05). The proportions of preoperative cardiac function Killip grade ≥ 2 and number of patients using preoperative intra-aortic balloon pump were significantly different (p < 0.05). Multivariate logistic regression analysis showed that age > 65 years (OR: 1.471; 95% CI: 1.462-1.492; p = 0.007), reperfusion time > 6 hours (OR: 1.274; 95% CI: 1.164-1.405; p = 0.001), low systolic pressure at admission (< 100 mmHg) (OR: 1.918; 95% CI: 1.017-3.897; p = 0.004), intra-aortic balloon pump use before percutaneous coronary intervention (OR: 1.949; 95% CI: 1.168-3.253; p = 0.011), low TIMI grade (≤ 1) before percutaneous coronary intervention (OR: 1.100; 95% CI: 1.086-1.257; p < 0.01), high thrombus load (OR: 1.274; 95% CI: 1.423-2.761; p = 0.030), and long target lesion (OR: 1.948; 95% CI: 1.908-1.990; p = 0.019) were independent risk factors.
CONCLUSIONS: No-reflow phenomenon after percutaneous coronary intervention in patients with acute coronary syndrome was affected by complicated pathological factors.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28613283     DOI: 10.24875/ric.17002190

Source DB:  PubMed          Journal:  Rev Invest Clin        ISSN: 0034-8376            Impact factor:   1.451


  7 in total

Review 1.  A Narrative Review of the Classical and Modern Diagnostic Methods of the No-Reflow Phenomenon.

Authors:  Larisa Renata Pantea-Roșan; Simona Gabriela Bungau; Andrei-Flavius Radu; Vlad Alin Pantea; Mădălina Ioana Moisi; Cosmin Mihai Vesa; Tapan Behl; Aurelia Cristina Nechifor; Elena Emilia Babes; Manuela Stoicescu; Daniela Gitea; Diana Carina Iovanovici; Cristiana Bustea
Journal:  Diagnostics (Basel)       Date:  2022-04-08

2.  Effect of sequential nicorandil on myocardial microcirculation and short-term prognosis in acute myocardial infarction patients undergoing coronary intervention.

Authors:  Shu-Fang Pi; Ying-Wu Liu; Tong Li; Yu Wang; Quan Zhou; Bo-Jiang Liu; Wen-Jin Peng; Xin Li; Yun-Yun Wang; Lei Huang
Journal:  J Thorac Dis       Date:  2019-03       Impact factor: 2.895

3.  Relationship between alkaline phosphatase and impaired coronary flow in patients with ST-segment elevated myocardial infarction.

Authors:  Efe Edem
Journal:  J Int Med Res       Date:  2018-07-05       Impact factor: 1.671

4.  The relationship between hemoglobin A1c levels and thrombus load in patients with type 2 diabetes mellitus and non-ST-segment elevation myocardial infarction.

Authors:  Dursun Topal; Ferit Onur Mutluer; Omur Aydin; Hakan Cakir; Selcuk Kanat; Burhan Aslan; Fahri Er; Abdulkadir Uslu; Veciha Ozlem Bozkaya; Muhammed Keskin; Remzi Karşı; Mustafa Yılmaz; Enbiya Aksakal; Mehmet Demir; Erhan Tenekecioglu
Journal:  J Res Med Sci       Date:  2021-11-29       Impact factor: 1.852

5.  Predictive value of N-terminal pro-B-type natriuretic peptide (NT-pro BNP) combined with D-dimer for no-reflow phenomenon in patients with acute coronary syndrome after emergency of percutaneous coronary intervention.

Authors:  Yujing Diao; Meifeng Yin; Baoguo Zhang; Bin Sun
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  Effect of nicorandil treatment adjunctive to percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis.

Authors:  Jin Zhou; Jing Xu; Aijuan Cheng; Peng Li; Bingwei Chen; Shan Sun
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

7.  Intracoronary and peripheral blood levels of TNF-like Cytokine 1A (TL1A) in patients with acute coronary syndrome.

Authors:  Xinjing Chen; Yansong Guo; Li Lai; Shengli Zhang; Zhiliang Li
Journal:  Medicine (Baltimore)       Date:  2020-05-29       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.